Sports

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 18,068 Shares of Amdocs Limited $DOX

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 18,068 Shares of Amdocs Limited $DOX

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Amdocs Limited (NASDAQ:DOX – Free Report) by 3.9% during the first quarter, Holdings Channel.com reports. The fund owned 477,898 shares of the technology company’s stock after buying an additional 18,068 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC’s holdings in Amdocs were worth $43,728,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in DOX. Alyeska Investment Group L.P. boosted its holdings in shares of Amdocs by 38.6% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock worth $213,174,000 after purchasing an additional 648,693 shares in the last quarter. American Century Companies Inc. lifted its holdings in Amdocs by 23.5% in the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock worth $205,219,000 after buying an additional 426,911 shares during the period. Nuveen LLC purchased a new stake in Amdocs in the 1st quarter worth approximately $36,921,000. LSV Asset Management lifted its holdings in Amdocs by 11.1% in the 1st quarter. LSV Asset Management now owns 3,180,501 shares of the technology company’s stock worth $291,016,000 after buying an additional 317,412 shares during the period. Finally, AQR Capital Management LLC raised its position in shares of Amdocs by 43.0% in the 1st quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company’s stock worth $86,719,000 after acquiring an additional 287,243 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.
Get Amdocs alerts:
Amdocs Price Performance
NASDAQ:DOX opened at $85.00 on Monday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The business’s 50-day simple moving average is $87.18 and its two-hundred day simple moving average is $88.54. The stock has a market cap of $9.60 billion, a PE ratio of 17.24, a P/E/G ratio of 1.55 and a beta of 0.54. Amdocs Limited has a 52 week low of $78.61 and a 52 week high of $95.41.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.13 billion. During the same period in the previous year, the firm posted $1.62 earnings per share. The business’s revenue was down 8.4% compared to the same quarter last year. As a group, analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.527 dividend. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs’s payout ratio is 42.60%.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the company. Wolfe Research started coverage on Amdocs in a research report on Tuesday, July 8th. They issued an “outperform” rating for the company. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research report on Sunday, August 10th. Four investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $105.33.
View Our Latest Report on Amdocs
Amdocs Profile
(Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
Five stocks we like better than Amdocs
What is the S&P/TSX Index?
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside
Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
Football Season Is Here and DraftKings Stock Is Surging
What Are Growth Stocks and Investing in Them
RH Stock Slides After Mixed Earnings and Tariff Concerns
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).